Hasil Pencarian (2)
biotech | CAS: 1418205-77-2
Bimekizumab is a humanized monoclonal antibody directed towards IL-17, which was approved for use in the EU on August 20, 2021, for the treatment of plaque psoriasis.[L39665,L39680] It is the first IL-17 inhibitor to target both IL-17A and IL-17F.[A244455] It…
Kategori:
Agents reducing cytokine levelsAmino Acids, Peptides, and ProteinsAntibodies
+11
Target Protein:
Interleukin-17AInterleukin-17F
Waktu ParuhThe mean terminal e…
Vol. DistribusiIn patients with pl…
KlirensThe median apparent…
Genetik
-
biotech | CAS: 815610-63-0
Ustekinumab is a human immunoglobulin (Ig) G1 kappa monoclonal antibody directed against interleukin(IL)-12 and IL-23, which are cytokines that are involved in immune and inflammatory responses.[A187349] It was generated via recombinant human IL-12 immunizati…
Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal
+16
Target Protein:
Interleukin-23Interleukin-12 subunit beta
Waktu ParuhFollowing administr…
Vol. DistribusiThe total volume of…
KlirensThe median apparent…
Genetik
-